|
SEED Finalists Coaching Day - Detailed Agenda
|
|
March 2, 2010 (Tuesday), Shanghai
|
|
Time
|
Title/Description
|
Speakers
|
|
08:30 - 09:00
|
Registration and Refreshments
|
|
|
09:00 - 09:10
|
Welcome Remarks
|
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
09:10 - 09:40
|
Life Science Landscape and Growth Areas
China life science companies are now playing on a global stage, and the whole world is watching. Learn how the industry is evolving, and what areas represent the greatest potential for future growth.
|
Franck Le Deu, MBA - Principal, McKinsey & Company
|
|
09:40 - 10:10
|
Life Science Equity Market and Exit Strategies
For life science entrepreneurs and investors, the ultimate reward is received when their company exits through either an IPO or merger/acquisition. Gain insights into the role of the stock markets and how to position your company to become a public company or to be acquired.
|
Bin Li, PhD - Senior Research Analyst/Executive Director, Greater China Healthcare, Morgan Stanley
|
|
10:10 - 10:40
|
Break and Refreshments
|
|
|
10:40 - 11:10
|
The Importance of IP in Life Science: A Case Study
Intellectual property is often the cornerstone of a life science company. Without a strong, global patent portfolio, the value of the company may be diminished, decreasing the likelihood of receiving funding. A case study provides guidance on how to improve your IP strategy and successfully position your company for funding.
|
Michael J. Wise, JD - Partner, Perkins Coie
|
|
11:10 - 11:40
|
To be or Not to be An Entrepreneur
As founder and CEO of BioExplorer and now General Manager of Charles River's China operation, Dr. Kewen (Kevin) Jin is regarded as a legend in China's life science industry. Hear him describe his experiences as an early entrepreneur in China, and considerations you should make before making the leap to run your own company.
|
Kewen Jin, PhD - General Manager, Charles River Greater China
|
|
11:40 - 13:00
|
Luncheon
|
|
|
13:00 - 14:00
|
Business Plan Presentations: Case Studies
A company's business plan presentation can make or break the company, but what makes one effective and another not is not always obvious. This interactive session will have two "entrepreneurs" present mock business plans to a panel of executives and VCs who will determine what is good - and what is bad.
|
Moderator:
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
Presenters:
Stefan Chen, PhD - Engagement Manager, McKinsey & Company
|
|
Lefei Sun, PhD - Associate, OrbiMed Asia
|
|
Panelists:
Ying Chen, PhD - Senior Engagement Manager, McKinsey & Company
|
|
Kewen Jin, PhD - General Manager, Charles River Greater China
|
|
Lan Kang, MBA - Client Partner, Korn/Ferry International
|
|
Bin Li, PhD - Senior Research Analyst/Executive Director, Greater China Healthcare, Morgan Stanley
|
|
Joseph S. McCracken, DVM - Head of Pharma Partnering Asia, Roche Global Pharma Partnering
|
|
Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia
|
|
Michael J. Wise, JD - Partner, Perkins Coie
|
|
14:00 - 15:00
|
SEED Finalists Award Ceremony
The finalists of the SEED Competition will be announced and receive their awards.
|
|
|
15:00 - 17:00
|
SEED Finalists Coaching Sessions
The finalists will have the opportunity to meet with industry executives, investors, and advisors to receive coaching on their business plan presentations. These sessions are designed to help the finalists prepare the best possible presentation to be given at the SEED Final Competition and Award Ceremony.
|
Ying Chen, PhD - Senior Engagement Manager, McKinsey & Company
|
|
Frank Grams, PhD - Executive Director, Roche Global Pharma Partnering
|
|
Lu Huang, MD, MBA - Director, Morningside
|
|
Kewen Jin, PhD - General Manager, Charles River Greater China
|
|
Lan Kang, MBA - Client Partner, Korn/Ferry International
|
|
Joseph S. McCracken, DVM - Head of Pharma Partnering Asia, Roche Global Pharma Partnering
|
|
Greg B. Scott - President & Founder, ChinaBio® LLC
|
|
Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia
|
|
Zoe Wang, PhD, JD - Partner, Perkins Coie LLP
|
|
Michael J. Wise, JD - Partner, Perkins Coie LLP
|
|
Stella Xu, PhD - Executive Director, Roche Global Pharma Partnering
|
|
17:00 - 18:00
|
SEED Business Plan Competition Reception
|
|
_1258685896.jpg){kind=logo}
